
Sano Chemicals: Pioneering biotech firm developing novel anti-infectives and cancer treatments.
Founded with a mission to combat infectious diseases and cancer, Sano Chemicals is a pioneering biotechnology firm dedicated to developing novel anti-infectives and cancer treatments. Through rigorous research and development, the company aims to provide first-in-class treatment options for acute and chronic illnesses. Their flagship product, Occidiofungin, is a groundbreaking treatment for serious fungal infections, particularly targeting recurrent vulvovaginal candidiasis and systemic fungal infections in immunocompromised patients.
Sano Chemicals has garnered attention from notable figures in the biotech industry and has secured investments from leading venture capital firms specializing in healthcare innovation. The company's key achievements include significant advancements in the treatment of fungal infections, positioning Occidiofungin as a potential game-changer in the field. With its innovative solutions, Sano Chemicals is poised to make a substantial impact on public health by addressing unmet medical needs and improving patient outcomes.

Sano
sanodx.com

Sano Informed Prescribing
thinksano.com

SaNOtize
sanotize.com

WinSanTor
winsantor.com

Scynexis
scynexis.com

Noxsano
noxsano.com

Kathera Bioscience
katherabio.com

MiniVax

Sancilio & Company
sancilio.com

MycoMed Technologies

Nano Cures
nanocures.com

Mycologics
mycologics.net

Revagenix
revagenix.com

Spectrum Antimicrobials

SanaRx Biotherapeutics
Companies similar to Sano Chemicals include Sano, Sano Informed Prescribing, SaNOtize and WinSanTor.
Sano Chemicals was founded in 2012.
Sano Chemicals' headquarters is located in Bryan, TX, US.
Sano Chemicals' most recent funding round was for $710k (USD) in January 2024.
As of Jan 8, 2024, Sano Chemicals has raised a total of $720k (USD).
Sano Chemicals has 32 employees as of Feb 5, 2024.